Impact of low dose atorvastatin on development of new-onset diabetes mellitus in Asian population: Three-year clinical outcomes

Ji , Ji Young Park and Seung , Seung Woon Rha and Jae , Woong Choi and Sung , Kee Ryu and Seunghwan, Kim and Yung, Kyun Noh and Se , Yeon Choi and Raghavender , Goud Akkala and Hu, Li and Ali, Jabar and Shaopeng , Xu and Ngow, Harris Abdullah and Jae, Joong Lee and Gwang , No Lee and Jibak, Kim and Sunki , Lee and Jin , Oh Na and Cheol, Ung Choi and Hong, Euy Lim and Jin, Won Kim and Englu, Kim and Chang , Gyu Park and Hong, Seog Seo and Dong, Joo Oh (2015) Impact of low dose atorvastatin on development of new-onset diabetes mellitus in Asian population: Three-year clinical outcomes. International Journal of Cardiology, 184. pp. 502-506. ISSN 0167-5273

PDF (Journal) - Published Version Restricted to Registered users only Download (419kB) | Request a copy

Abstract

High dose atorvastatin is known to be associated with new onset diabetes mellitus (NODM) in patients with high risk for developing diabetes mellitus (DM). However, low dose atorvastatin is more commonly used as compared with high dose atorvastatin. The aim of this study is to investigate the impact of low dose atorvastatin (LDA, 10 mg or 20 mg) on the development of NODM up to three years in Asian patients. From January 2004 to September 2009, we investigated a total of 3566 patients who did not have DM. To adjust for potential confounders, a propensity score matching (PSM) analysis was performed using the logistic regression model. After PSM (C-statistics: 0.851), a total of 818 patients (LDA group, n = 409 patients and control group, n = 409 patients) were enrolled for analysis. Before PSM, the cumulative incidence of NODM (5.8% vs. 2.1%, p < 0.001), myocardial infarction (0.5% vs. 0.1%, p-value = 0.007), and major adverse cardio-cerebral event (MACCE, 1.8% vs. 0.7%, p-value = 0.012) at three-years were higher in the LAD group. However, after PSM, there was a trend toward higher incidence of NODM (5.9% vs. 3.2%, p = 0.064) in the LDA group, but the incidence of MACCE (1.2% vs. 1.5%, p-value = 1.000) was similar between the two groups. In multivariable analysis, the LDA administration was tended to be an independent predictor of NODM (OR: 1.99, 95% CI: 1.00–3.98, p-value 0.050). In this study, the use of LDA tended to be a risk factor for NODM in Asian patients and reduced clinical events similar to the control group. However, large-scale randomized controlled trials will be needed to get the final conclusion.

Item Type:	Article (Journal)
Additional Information:	4393/42707
Uncontrolled Keywords:	Atorvastatin, New onset diabetes mellitus
Subjects:	R Medicine > RC Internal medicine
Kulliyyahs/Centres/Divisions/Institutes (Can select more than one option. Press CONTROL button):	Kulliyyah of Medicine > Department of Internal Medicine
Depositing User:	Mrs Noor Azlin Asnam
Date Deposited:	20 Apr 2015 10:25
Last Modified:	03 Jul 2015 15:32
URI:	http://irep.iium.edu.my/id/eprint/42707

Actions (login required)

View Item